Brian A. Kirk

464 total citations
11 papers, 330 citations indexed

About

Brian A. Kirk is a scholar working on Molecular Biology, Organic Chemistry and Infectious Diseases. According to data from OpenAlex, Brian A. Kirk has authored 11 papers receiving a total of 330 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Infectious Diseases. Recurrent topics in Brian A. Kirk's work include HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Organometallic Complex Synthesis and Catalysis (2 papers). Brian A. Kirk is often cited by papers focused on HIV Research and Treatment (3 papers), HIV/AIDS drug development and treatment (3 papers) and Organometallic Complex Synthesis and Catalysis (2 papers). Brian A. Kirk collaborates with scholars based in United States and Canada. Brian A. Kirk's co-authors include Spencer Knapp, Stephen G. Withers, David J. Vocadlo, Zhinong Gao, Nancy S. Barta, John R. Stille, Joseph Duffy, James R. Tata, William A. Schleif and Lixia Jin and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Tetrahedron Letters.

In The Last Decade

Brian A. Kirk

11 papers receiving 323 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Brian A. Kirk United States 9 237 226 56 55 31 11 330
Yohji Ezure Japan 14 285 1.2× 261 1.2× 72 1.3× 18 0.3× 28 0.9× 31 478
Sybrin P. Schröder Netherlands 11 227 1.0× 259 1.1× 72 1.3× 52 0.9× 8 0.3× 19 414
Jürgen Schweden Germany 10 378 1.6× 271 1.2× 87 1.6× 42 0.8× 87 2.8× 12 443
Wenling Dong France 6 222 0.9× 244 1.1× 51 0.9× 43 0.8× 10 0.3× 8 382
Matthew B. Kraft United States 12 280 1.2× 272 1.2× 104 1.9× 15 0.3× 60 1.9× 14 499
C. J. J. Elie Netherlands 13 268 1.1× 302 1.3× 55 1.0× 31 0.6× 8 0.3× 20 431
Torsten Wiemann Germany 12 270 1.1× 222 1.0× 66 1.2× 8 0.1× 16 0.5× 17 368
Matthew C. Stevens United States 7 91 0.4× 187 0.8× 34 0.6× 22 0.4× 11 0.4× 8 362
Vincent A. Boyd United States 12 234 1.0× 188 0.8× 32 0.6× 12 0.2× 15 0.5× 21 437
Erwin R. van Rijssel Netherlands 11 214 0.9× 301 1.3× 41 0.7× 32 0.6× 4 0.1× 14 356

Countries citing papers authored by Brian A. Kirk

Since Specialization
Citations

This map shows the geographic impact of Brian A. Kirk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian A. Kirk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian A. Kirk more than expected).

Fields of papers citing papers by Brian A. Kirk

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian A. Kirk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian A. Kirk. The network helps show where Brian A. Kirk may publish in the future.

Co-authorship network of co-authors of Brian A. Kirk

This figure shows the co-authorship network connecting the top 25 collaborators of Brian A. Kirk. A scholar is included among the top collaborators of Brian A. Kirk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian A. Kirk. Brian A. Kirk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Smagghe, Benoit J., Andrew K. Stewart, Mark G. Carter, et al.. (2013). MUC1* Ligand, NM23-H1, Is a Novel Growth Factor That Maintains Human Stem Cells in a More Naïve State. PLoS ONE. 8(3). e58601–e58601. 21 indexed citations
2.
Duffy, Joseph, Brian A. Kirk, Liping Wang, et al.. (2007). 4-Aminophenylalanine and 4-aminocyclohexylalanine derivatives as potent, selective, and orally bioavailable inhibitors of dipeptidyl peptidase IV. Bioorganic & Medicinal Chemistry Letters. 17(10). 2879–2885. 15 indexed citations
3.
Cohen, Sheila M., Joseph Duffy, Corin O. Miller, et al.. (2005). Direct observation (NMR) of the efficacy of glucagon receptor antagonists in murine liver expressing the human glucagon receptor. Bioorganic & Medicinal Chemistry. 14(5). 1506–1517. 13 indexed citations
4.
Duffy, Joseph, Brian A. Kirk, Kevin T. Chapman, et al.. (2003). HIV-1 protease inhibitors with picomolar potency against PI-resistant HIV-1 by modification of the P1′ substituent. Bioorganic & Medicinal Chemistry Letters. 13(19). 3323–3326. 10 indexed citations
5.
Duffy, Joseph, Brian A. Kirk, Kevin T. Chapman, et al.. (2003). Novel HIV-1 protease inhibitors active against multiple PI-Resistant viral strains: coadministration with indinavir. Bioorganic & Medicinal Chemistry Letters. 13(22). 4027–4030. 13 indexed citations
6.
Knapp, Spencer & Brian A. Kirk. (2003). Glycosylation with 2′-thio-S-acetyl participation. Tetrahedron Letters. 44(41). 7601–7605. 11 indexed citations
7.
Duffy, Joseph, Brian A. Kirk, Kevin T. Chapman, et al.. (2002). Synthesis and activity of novel HIV protease inhibitors with improved potency against multiple PI-resistant viral strains. Bioorganic & Medicinal Chemistry Letters. 12(17). 2423–2426. 11 indexed citations
8.
Knapp, Spencer, Brian A. Kirk, David J. Vocadlo, & Stephen G. Withers. (1997). An Allosamizoline/Glucosamine Hybrid NAGase Inhibitor. Synlett. 1997(Sup. I). 435–436. 7 indexed citations
9.
Knapp, Spencer, et al.. (1996). NAG-thiazoline, An N-Acetyl-β-hexosaminidase Inhibitor That Implicates Acetamido Participation. Journal of the American Chemical Society. 118(28). 6804–6805. 215 indexed citations
10.
Barta, Nancy S., Brian A. Kirk, & John R. Stille. (1995). Competitive intramolecular TiC versus AlC alkene insertions: Examining the role of Lewis acid cocatalysts in Ziegler-Natta alkene insertion and chain transfer reactions. Journal of Organometallic Chemistry. 487(1-2). 47–53. 5 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yohji Ezure Breakdown of academic impact, for papers by Sybrin P. Schröder Breakdown of academic impact, for papers by Jürgen Schweden Breakdown of academic impact, for papers by Wenling Dong Breakdown of academic impact, for papers by Matthew B. Kraft Breakdown of academic impact, for papers by C. J. J. Elie Breakdown of academic impact, for papers by Torsten Wiemann Breakdown of academic impact, for papers by Matthew C. Stevens Breakdown of academic impact, for papers by Vincent A. Boyd Breakdown of academic impact, for papers by Erwin R. van Rijssel
Rankless by CCL
2026